RegisterLogin

VPC-14449

CAT: 804-HY-116501-01Size: 5 mgDry Ice: NoHazardous: No
5 mgSelected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
VPC-14449 is a potent and selective inhibitor of the DNA-binding domain of the androgen receptor (AR-DBD), with IC50 of 0.34 μM for full-length human AR. VPC-14449 reduces the ability of full-length AR as well as AR variants to interact with chromatin. VPC-14449 can be used for the research of prostate cancer[1][2].
CAS Number
[1621375-32-3]
UNSPSC
12352005
Target
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vpc-14449.html
Concentration
10mM
Purity
99.51
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
BrC1=CN(C2=CSC(N3CCOCC3)=N2)C(Br)=N1
Molecular Formula
C10H10Br2N4OS
Molecular Weight
394.09
References & Citations
[1]Dalal K, et, al. Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer. J Biol Chem. 2014 Sep 19;289 (38) :26417-26429.|[2]Dalal K, et, al. Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin Interactions. Mol Cancer Ther. 2017 Oct;16 (10) :2281-2291.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-118409VPC-3033
HY-139970VPC-13789
HY-122234-01VPC-18005
HY-117669-01VPC-14228
HY-147291-01VPC-70063
HY-126076A-01VPC-80051
HY-108490-01VPC 23019
HY-144878-01VPC-70619
HY-120018-01VPC-13566
HY-126076-01VPC-80051 (racemate)

Alternative Products

CatalogName
BA9177-5.1VPC-14449
T24944-01VPC-14449
M12386-01VPC 14449
BUP20508-01VPC-14449
MBS3602386-01VPC 14449
MBS5774684VPC-14449
BA9177-5VPC-14449
BA9177-10VPC-14449
BA9177-1VPC-14449
MBS3617052-01VPC-18005

Popular Products